Marlio Charles Mosseri - 30 Jun 2026 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Reporting relationship: 10%+ Owner
Issuer ticker: NVCT
Reported as of: 30 Jun 2026
Net transaction value: +$916,000
SEC form: 4
Accepted by SEC: 01 Jul 2026, 13:41:50 UTC
Prior SEC filing: 29 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Charles Mosseri-Marlio

Key filing fact

Marlio Charles Mosseri filed Form 4 for Nuvectis Pharma, Inc. (NVCT) on 01 Jul 2026.

Key facts

This page summarizes Marlio Charles Mosseri's Form 4 filing for Nuvectis Pharma, Inc. (NVCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 13:41.

Change

Previous filing in this sequence was filed on 29 Oct 2025.
Current net transaction value: +$916,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001806384 Primary reporting owner

Mosseri Marlio Charles

Relationship: 10%+ Owner
Address: 27 RIPPLEVALE GROVE, LONDON, UNITED KINGDOM
Signature: /s/ Charles Mosseri-Marlio
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVCT transaction

Common Stock

Purchase

Transaction value: $916,000
Shares: +50,000
Change %: +1.6%
Price: $18.32
Shares after: 3,186,576
Date: 30 Jun 2026
Ownership: By Emerald Hill Ventures SARL SPF.
Footnotes: F1, F2

NVCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 109,321
Date: 30 Jun 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.29 to $18.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.